Noevir Holdings Co., Ltd. (TYO:4928)
Japan · Delayed Price · Currency is JPY 4,755.00
+40.00 (0.85%)
Jan 23, 2026, 3:30 PM JST
Noevir Holdings Revenue
In the fiscal year ending September 30, 2025, Noevir Holdings had annual revenue of 64.72B JPY with 1.41% growth. Noevir Holdings had revenue of 17.44B in the quarter ending September 30, 2025, with 11.91% growth.
Revenue
64.72B
Revenue Growth
+1.41%
P/S Ratio
2.49
Revenue / Employee
47.80M
Employees
1,354
Market Cap
161.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 64.72B | 901.00M | 1.41% |
| Sep 30, 2024 | 63.82B | 1.27B | 2.03% |
| Sep 30, 2023 | 62.55B | 1.41B | 2.30% |
| Sep 30, 2022 | 61.14B | 9.87B | 19.25% |
| Sep 30, 2021 | 51.27B | -569.00M | -1.10% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Paltac | 1.21T |
| KOSE Holdings | 324.54B |
| Earth | 177.37B |
| Pola Orbis Holdings | 169.97B |
| Kobayashi Pharmaceutical | 163.18B |
| Pigeon | 108.66B |
| MTG Co., Ltd. | 98.81B |
| Mandom | 78.25B |